Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of HIV resistance testing after prolonged treatment interruption.

Journal of acquired immune deficiency syndromes (1999) - 1 Mar 2010

Iarikov Dmitri E, Irizarry-Acosta Melina, Martorell Claudia, Rauch Carol A, Hoffman Robert P, Skiest Daniel J

Abstract excerpt

BACKGROUND: HIV-1 genotypic resistance testing is not routinely recommended for patients who have been off antiretroviral therapy (ART) for longer than 4 weeks. We assessed the results and use of resistance testing in patients off ART. METHODS: All HIV resistance genotypes from November 2003 through April 2008 were reviewed from one large teaching hospital and two private HIV practices. Inclusion criterion was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Microbial Sensitivity Tests

Share to Mutation, Missense

Share to Time Factors

Share to Viral Proteins

Share to Young Adult

Source

Identifiers

PMID: 20009764
DOI: 10.1097/QAI.0b013e3181c79ab0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of HIV resistance testing after prolonged treatment interruption.PMID 20009764Read ↗

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.Semantic proximity Read ↗

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapySemantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.Semantic proximity Read ↗

Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.Semantic proximity Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.Semantic proximity Read ↗

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.Semantic proximity Read ↗

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.